Back
Keros Therapeutics Stock Predictions
Sponsored
KROS
Sponsored
S&P Global: Private Equity Invests $36 Billion Into What?
Read More
Sell
43
KROS
Keros Therapeutics
Last Price:
64.62
Seasonality Move:
-23.47%
7 Day Trial
ALL ACCESS PASS
$
7
Biden's Oil War: The Administration Is All-In on Green Energy.
Download Free ReportKeros Therapeutics Stock Forecast
- Over the next 52 weeks, Keros Therapeutics has on average historically risen by 6.6% based on the past 3 years of stock performance.
- Keros Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Keros Therapeutics Stock Undervalued?
The current Keros Therapeutics [KROS] share price is $64.59. The Score for KROS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal. - KROS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Keros Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Keros Therapeutics has on average historically risen by 6.6% based on the past 3 years of stock performance.
Keros Therapeutics Stock Rating
Sell
43
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics overpriced?
- Keros Therapeutics has risen higher in 1 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Keros Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
kerostx.com
52-Week Data
52-Week High:
73.00
52-Week Low:
27.02
Prediction Charts
Market Cap:
2.32B
Price in USD:
64.59
Volume:
436.22K
Beta:
1.17
Technical Analysis
SMA50:
61.19
SMA100:
48.54
SMA200:
42.19
52-Wk Change:
54.78%
Stock Predictions
-
Is Keros Therapeutics stock public?
Yes, Keros Therapeutics is a publicly traded company. -
What is the Keros Therapeutics stock quote today?
The Keros Therapeutics stock price is 64.59 USD today. -
How to buy Keros Therapeutics stock online?
You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Mar-8 | 69.68 | 70.55 | 71.29 | 69.14 |
Mar-11 | 69.90 | 66.31 | 70.58 | 65.75 |
Mar-12 | 66.36 | 67.54 | 69.69 | 65.78 |
Mar-13 | 67.68 | 67.77 | 69.63 | 66.80 |
Mar-14 | 67.02 | 64.87 | 67.25 | 63.64 |
Mar-15 | 64.24 | 67.35 | 68.30 | 64.24 |
Mar-18 | 66.93 | 63.79 | 67.12 | 63.62 |
Mar-19 | 63.58 | 64.20 | 65.06 | 62.79 |
Mar-20 | 64.03 | 66.99 | 67.00 | 63.24 |
Mar-21 | 67.65 | 68.92 | 69.89 | 66.85 |
Mar-22 | 69.26 | 65.86 | 69.26 | 65.36 |
Mar-25 | 65.52 | 66.26 | 67.42 | 65.52 |
Mar-26 | 67.27 | 66.12 | 67.49 | 65.22 |
Mar-27 | 59.20 | 64.59 | 65.86 | 59.14 |
Keros Therapeutics Earnings
Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Keros Therapeutics Forecast Revenue Growth
Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.02 per share, an increase next quarter of $0.20 per share, an increase this year of $0.03 per share, and a decrease next year of $0.37 per share.
* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.